搜索临床试验以:吡咯替尼、曲妥珠单抗、多西紫杉醇
总计3271个结果
-
First Affiliated Hospital of Zhejiang University招聘中
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir Run Run Shaw Hospital 和其他合作者未知
-
Shandong University未知
-
Peking University Cancer Hospital & Institute尚未招聘
-
The First Affiliated Hospital with Nanjing Medical...Anhui Provincial Cancer Hospital; Affiliated Hospital of Jiangnan University; The Affiliated Nanjing... 和其他合作者招聘中
-
AstraZenecaDaiichi Sankyo完全的乳腺癌丹麦, 芬兰, 意大利, 挪威, 西班牙, 瑞典, 波兰, 美国, 加拿大, 德国, 日本, 荷兰, 葡萄牙, 瑞士, 澳大利亚, 英国, 比利时, 爱尔兰
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Yonsei University尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Shengjing Hospital尚未招聘
-
Shandong Cancer Hospital and Institute未知转移性乳腺癌 | HER2阳性乳腺癌
-
Fujian Medical University Union Hospital招聘中
-
European Organisation for Research and Treatment...GlaxoSmithKline完全的
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; Cephalon完全的
-
Caigang LiuJiangsu HengRui Medicine Co., Ltd.招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis Pharmaceuticals终止
-
QuantumLeap Healthcare CollaborativeByondis B.V.撤销卵巢癌 | 转移癌 | 转移性乳腺癌 | 膀胱癌 | 三阴性乳腺癌 | HER2阳性乳腺癌 | 胃食管腺癌 | 卵巢癌 | HER2阳性胃癌 | 转移性胃肠道类癌 | HER2阳性转移性乳腺癌 | 孕激素受体阳性乳腺癌 | 胃食管癌 | 雌激素受体阳性肿瘤 | 激素受体阳性乳腺癌 | 转移性 | HER-2 蛋白过表达 | 激素受体阴性乳腺癌 | HER2低 | SYD-985 | SYD985 | Vic-trastuzumab Duocarmazine | HER2低位乳腺癌 | 子宫内膜肿瘤 | HER2突变相关肿瘤 | HER2 低 HR 阳性 | 人力资源积极美国
-
Biocon Biologics UK Ltd尚未招聘HR 阴性 HER2 阳性早期乳腺癌或局部晚期乳腺癌患者
-
Jiangsu HengRui Medicine Co., Ltd.招聘中非鳞状非小细胞肺癌 | HER2 外显子 20 突变大韩民国, 美国, 台湾, 比利时, 西班牙, 中国, 澳大利亚, 火鸡, 意大利, 法国, 德国, 波兰, 俄罗斯联邦
-
Shandong Cancer Hospital and Institute未知
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Cancer Trials Ireland完全的